Bifurcation Lesion in a High Bleeding Risk Patient
Details
-
Emphasize the importance of defining high bleeding risk in patients undergoing PCI
-
Increase identification of high bleeding risk patients and learn how to apply this in your clinical practice
-
Exchange on the contemporary treatment strategies for bifurcation lesions using the Visible Heart® content and reflect on practical cases
Raising awareness and identifying high bleeding risk patients / ARC HBR app Dr. Colleran/Prof. Burzotta
Clinical case
Treating a bifurcation lesion in a high bleeding risk patient
Dr. Colleran/Prof. Burzotta
Organised by
Francesco Burzotta
Interventional Cardiologist in Interventional cardiology department of Fondazione Policlinico...
Read MoreInterventional Cardiologist in Interventional cardiology department of Fondazione Policlinico Universitario A.Gemelli. Professor and university researcher in cardiovascular science and thoracic department in University Cattolica del Sacro Cuore. An interventional cardiologist at Catholic University of the Sacred Heart, Rome, Italy. Features in 11 videos on Wondr Medical. Francesco Burzotta generally speaks on Bifurcation, Left Main Stem (LMS), Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), and Calcified Lesions.
Show Less
Roisin Colleran
Dr Colleran is a Consultant interventional cardiologist at Mater Private Hospital Dublin and...
Read MoreDr Colleran is a Consultant interventional cardiologist at Mater Private Hospital Dublin and Cardiovascular Research Institute Dublin. Her specialty interests include general and interventional cardiology. Her areas of expertise include cardiac catheterisation, angioplasty and stenting, quantitative coronary angiography, optical coherence tomography, and coronary physiology. Her specific areas of interest are high-risk patient and lesions subsets undergoing percutaneous coronary intervention, patients at high bleeding risk, antithrombotic therapies in patients undergoing coronary stenting, drug-eluting stent and balloon technologies, myocardial revascularisation failure and structural intervention.
Show Less
